Channels - Polygenic risk score refines cardiovascular disease risk in individuals with type 2 diabetes at borderline or intermediate risk :: FRELIP Discovery

Similar Items: Polygenic risk score refines cardiovascular disease risk in individuals with type 2 diabetes at borderline or intermediate risk

Quick Look
Clinical Characteristics of Diabetic Cardiovascular Autonomic Neuropathy in Korean Individuals With Type 2 Diabetes
Quick Look
Validation of the ST1RE risk engine in Chinese with type 1 diabetes and comparison with the JADE, RECODe, and UKPDS risk scores
Quick Look
Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A critical appraisal
Quick Look
Prevalence and Risk Factors for Iron Deficiency Anemia in Patients With Type 2 Diabetes in Jordan
Quick Look
Association between cardiometabolic risk factors cluster and all‐cause mortality in type 2 diabetes
Quick Look
Resistance Training in Cardiovascular Diseases: A Review on Its Effectiveness in Controlling Risk Factors
Quick Look
Diabetic foot ulcer‐related amputation is associated with twofold increased risk of cardiovascular disease: A Korean National Health Information Database Study
Quick Look
Low Subjective Cardiovascular Disease Risk Perceptions among Hypertensive Patients in Addis Ababa, Ethiopia
Quick Look
Biological and Social Risk Factors for Predicting Type 2 Diabetes in Youth with Prediabetes: Review of Existing Prediction Models
Quick Look
Prevalence of diagnostic Mendelian kidney disease variants in type 2 diabetes with and without diabetic kidney disease
Quick Look
Letter to the Editor in response to the article ‘Prevalence and risk factors of sarcopenia in Asian adults with type 2 diabetes: A systematic review and meta‐analysis’
Quick Look
Podcast Episode 3: How Can Physicians Work Collaboratively to Improve Cardiovascular Outcomes in Patients with Type 2 Diabetes?
Quick Look
The dietary pattern derived by reduced-rank regression in association with novel atherogenic risk factors in patients with type 2 diabetes: a cross-sectional study
Quick Look
Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category
Quick Look
Do the treatment selection factors emphasized in clinical guidelines—Chronic kidney disease, cardiovascular disease, and heart failure—contribute to the risk of urinary tract infections during the administration of sodium‐glucose cotransporter‐2 inhibitors?
Quick Look
Application of competing risks models in cardiovascular mortality research: findings from the Tehran lipid and glucose study
Quick Look
Cardiovascular Disease, Cancer and Dementia in Diabetes: 20‐Year Trends Will Necessitate New Treatment Priorities
Quick Look
Diabetic Retinopathy Severity and Heart Failure Outcomes in Type 2 Diabetes Mellitus
Quick Look
Prevalence and Severity of Coronary Artery Calcification Assessed by Low‐Dose Computed Tomography in Individuals With Type 2 Diabetes With and Without Diabetic Foot: A Cross‐Sectional Study
Quick Look
Lipid metabolism profiles as predictors of gestational diabetes mellitus risk: A retrospective study
Quick Look
Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response
Quick Look
Correction to “Association between continuous glucose monitoring metrics and diabetic retinopathy and albuminuria among Japanese individuals with type 1 diabetes”
Quick Look
Interaction of genetic risk score and fatty acids quality index on circadian rhythm and quality of life among overweight and obese women
Quick Look
Combined sleep behaviors, mediating biomarkers, and incident vascular complications among individuals with type 2 diabetes: A prospective study in UK Biobank